208 related articles for article (PubMed ID: 21071580)
1. Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice.
Shimizu M; Sakai H; Shirakami Y; Iwasa J; Yasuda Y; Kubota M; Takai K; Tsurumi H; Tanaka T; Moriwaki H
Cancer Prev Res (Phila); 2011 Jan; 4(1):128-36. PubMed ID: 21071580
[TBL] [Abstract][Full Text] [Related]
2. Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice.
Iwasa J; Shimizu M; Shiraki M; Shirakami Y; Sakai H; Terakura Y; Takai K; Tsurumi H; Tanaka T; Moriwaki H
Cancer Sci; 2010 Feb; 101(2):460-7. PubMed ID: 19906067
[TBL] [Abstract][Full Text] [Related]
3. Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice.
Shimizu M; Sakai H; Shirakami Y; Yasuda Y; Kubota M; Terakura D; Baba A; Ohno T; Hara Y; Tanaka T; Moriwaki H
Cancer Prev Res (Phila); 2011 Mar; 4(3):396-403. PubMed ID: 21372039
[TBL] [Abstract][Full Text] [Related]
4. Metabolome Analyses Uncovered a Novel Inhibitory Effect of Acyclic Retinoid on Aberrant Lipogenesis in a Mouse Diethylnitrosamine-Induced Hepatic Tumorigenesis Model.
Qin XY; Tatsukawa H; Hitomi K; Shirakami Y; Ishibashi N; Shimizu M; Moriwaki H; Kojima S
Cancer Prev Res (Phila); 2016 Mar; 9(3):205-14. PubMed ID: 26744170
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
Terakura D; Shimizu M; Iwasa J; Baba A; Kochi T; Ohno T; Kubota M; Shirakami Y; Shiraki M; Takai K; Tsurumi H; Tanaka T; Moriwaki H
Carcinogenesis; 2012 Dec; 33(12):2499-506. PubMed ID: 23027617
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
[TBL] [Abstract][Full Text] [Related]
7. Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
Yasuda Y; Shimizu M; Shirakami Y; Sakai H; Kubota M; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Cancer Sci; 2010 Jul; 101(7):1701-7. PubMed ID: 20398056
[TBL] [Abstract][Full Text] [Related]
8. Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.
Shimizu M; Takai K; Moriwaki H
Cancer Sci; 2009 Mar; 100(3):369-74. PubMed ID: 19068086
[TBL] [Abstract][Full Text] [Related]
9. Synergistic growth inhibition by acyclic retinoid and vitamin K2 in human hepatocellular carcinoma cells.
Kanamori T; Shimizu M; Okuno M; Matsushima-Nishiwaki R; Tsurumi H; Kojima S; Moriwaki H
Cancer Sci; 2007 Mar; 98(3):431-7. PubMed ID: 17270033
[TBL] [Abstract][Full Text] [Related]
10. Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells.
Tatebe H; Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Tsurumi H; Moriwaki H
Cancer Lett; 2009 Nov; 285(2):210-7. PubMed ID: 19520494
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid.
Matsushima-Nishiwaki R; Okuno M; Takano Y; Kojima S; Friedman SL; Moriwaki H
Carcinogenesis; 2003 Aug; 24(8):1353-9. PubMed ID: 12807734
[TBL] [Abstract][Full Text] [Related]
12. Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/db obese mice.
Shimizu M; Yasuda Y; Sakai H; Kubota M; Terakura D; Baba A; Ohno T; Kochi T; Tsurumi H; Tanaka T; Moriwaki H
BMC Cancer; 2011 Jun; 11():281. PubMed ID: 21711565
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.
Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H
Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224
[TBL] [Abstract][Full Text] [Related]
14. Role of acyclic retinoid in the chemoprevention of hepatocellular carcinoma: basic aspects, clinical applications, and future prospects.
Shimizu M; Imai K; Takai K; Moriwaki H
Curr Cancer Drug Targets; 2012 Nov; 12(9):1119-28. PubMed ID: 22873214
[TBL] [Abstract][Full Text] [Related]
15. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
Shimizu M; Shirakami Y; Iwasa J; Shiraki M; Yasuda Y; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Clin Cancer Res; 2009 May; 15(9):3068-75. PubMed ID: 19366832
[TBL] [Abstract][Full Text] [Related]
16. Synergistic growth inhibition of human hepatocellular carcinoma cells by acyclic retinoid and GW4064, a farnesoid X receptor ligand.
Ohno T; Shirakami Y; Shimizu M; Kubota M; Sakai H; Yasuda Y; Kochi T; Tsurumi H; Moriwaki H
Cancer Lett; 2012 Oct; 323(2):215-22. PubMed ID: 22579649
[TBL] [Abstract][Full Text] [Related]
17. Acyclic retinoid, a novel synthetic retinoid, induces growth inhibition, apoptosis, and changes in mRNA expression of cell cycle- and differentiation-related molecules in human colon carcinoma cells.
Suzui M; Sunagawa N; Chiba I; Moriwaki H; Yoshimi N
Int J Oncol; 2006 May; 28(5):1193-9. PubMed ID: 16596235
[TBL] [Abstract][Full Text] [Related]
18. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.
Mittenbühler MJ; Sprenger HG; Gruber S; Wunderlich CM; Kern L; Brüning JC; Wunderlich FT
Mol Metab; 2018 Nov; 17():122-133. PubMed ID: 30224299
[TBL] [Abstract][Full Text] [Related]
19. Preventive effects of curcumin on the development of azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db obese mice.
Kubota M; Shimizu M; Sakai H; Yasuda Y; Terakura D; Baba A; Ohno T; Tsurumi H; Tanaka T; Moriwaki H
Nutr Cancer; 2012; 64(1):72-9. PubMed ID: 22172229
[TBL] [Abstract][Full Text] [Related]
20. Ezetimibe ameliorates cardiovascular complications and hepatic steatosis in obese and type 2 diabetic db/db mice.
Fukuda M; Nakamura T; Kataoka K; Nako H; Tokutomi Y; Dong YF; Yasuda O; Ogawa H; Kim-Mitsuyama S
J Pharmacol Exp Ther; 2010 Oct; 335(1):70-5. PubMed ID: 20651026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
